Adults 18 to 40, female only, with Pregnancy. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Changes in Maternal Ventilation During Labor AnalgesiaPrimary· Ventilation parameters measured at 2 hour and 4 hour
If Maternal Ventilation decreases following labor analgesia at 2 hour and 4 interval
Maternal ventilation at baseline
Group
Value
95% CI
Study Group
15.3
± 1
Maternal ventilation at 2 hours
Group
Value
95% CI
Study Group
12.6
± 1.1
Maternal Ventilation at 4 hor
Group
Value
95% CI
Study Group
13.8
± 1.2
If Maternal Temperature Increases During Labor AnalgesiaSecondary· 4 hours
If maternal temperature increases during labor analgesia
baseline temperature
Group
Value
95% CI
Ventilation During Labor Analgesia
98.1
± 0.4
Temperature at 4 hour
Group
Value
95% CI
Ventilation During Labor Analgesia
98.7
± 0.5
Sponsor's own description
Epidural techniques offer the advantage of being able to titrate the level, density, and duration of the blockade through the use of a catheter and are associated with relative maternal hemodynamic stability. One of the disadvantages, however, include a raise in maternal temperature that is attributed to labor epidural technique. This study will assess if decreased maternal ventilation following induction of labor analgesia causes a raise in temperature.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Brigham and Women's Hospital
Last refreshed: 19 March 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02339389.